Evidence map›Paper›PMID 28929108›Full record

ArticleBioMed research international2017

Different Cellular Response of Human Mesothelial Cell MeT-5A to Short-Term and Long-Term Multiwalled Carbon Nanotubes Exposure.

Li Ju, Wei Wu, Min Yu, Jianlin Lou, Hao Wu, Xianhong Yin, Zhenyu Jia, Yun Xiao, Lijin Zhu, Jun Yang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Li JuZhejiang Academy of Medical Sciences, Hangzhou, China.ORCID 0000-0002-4580-370X
Wei WuZhejiang Academy of Medical Sciences, Hangzhou, China.ORCID 0000-0002-4091-155X
Min YuZhejiang Academy of Medical Sciences, Hangzhou, China.
Jianlin LouZhejiang Academy of Medical Sciences, Hangzhou, China.ORCID 0000-0002-4052-7865
Hao WuZhejiang Academy of Medical Sciences, Hangzhou, China.
Xianhong YinJiading District Center for Disease Control and Prevention, Shanghai, China.
Zhenyu JiaZhejiang Academy of Medical Sciences, Hangzhou, China.
Yun XiaoZhejiang Academy of Medical Sciences, Hangzhou, China.
Lijin ZhuZhejiang Academy of Medical Sciences, Hangzhou, China.ORCID 0000-0002-8206-0570
Jun YangHangzhou Normal University School of Public Health, Hangzhou, China.ORCID 0000-0002-9401-3528
Zhejiang Academy of Medical Sciences · CNHangzhou Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite being a commercially important product, multiwalled carbon nanotubes (MWCNTs) continue to raise concerns over human health due to their structural similarity to asbestos. Indeed, exposure to MWCNT has been shown to induce lung cancer and even mesothelioma, but contradictory results also exist. To clarify the potentially carcinogenic effects of rigid and rod-like MWCNT and to elucidate the underlying mechanisms, the effects of MWCNT on human mesothelial cell MeT-5A were examined throughout 3 months of continuous exposure, including cytotoxicity, genotoxicity, and cell motility. It was found that MWCNT did not affect MeT-5A cell proliferation at 10

Indexed as

AsbestosCarcinogensCell LineCell MovementCell ProliferationDNA DamageHumansLung NeoplasmsMesotheliomaMesothelioma, MalignantNanotubes, CarbonTime FactorsAsbestosCarcinogensNanotubes, Carbon

Identifiers

PMID28929108
PMCPMC5591928
OpenAlexW2743832595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.